Zanoli L, Briet M, Empana JP, et al. Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society. J Hypertens. 2020;38:1682–98. https://doi.org/10.1097/HJH.0000000000002508. This is an important and detailed paper highlighting the importance of the vascular wall structure and its relationship to inflammation. It is a very comprehensive work of vascular homeostasis.
CAS Article PubMed PubMed Central Google Scholar
Bondareva O, Sheikh BN (2020) Vascular homeostasis and inflammation in health and disease-lessons from single cell technologies. Int J Mol Sci 21:.https://doi.org/10.3390/ijms21134688
Novikova OA, Laktionov PP, Karpenko AA. The roles of mechanotransduction, vascular wall cells, and blood cells in atheroma induction. Vascular. 2019;27:98–109. https://doi.org/10.1177/1708538118796063.
Mazurek R, Dave JM, Chandran RR, et al. Vascular cells in blood vessel wall development and disease. Adv Pharmacol. 2017;78:323–50. https://doi.org/10.1016/bs.apha.2016.08.001.
CAS Article PubMed Google Scholar
Elms SC, Toque HA, Rojas M, et al. The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes. Diabetologia. 2013;56:654–62. https://doi.org/10.1007/s00125-012-2789-5.
CAS Article PubMed Google Scholar
Govindpani K, Vinnakota C, Waldvogel HJ, et al. Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target. Neural Regen Res. 2020;15:1030–2. https://doi.org/10.4103/1673-5374.270306.
Tsang HG, Rashdan NA, Whitelaw CBA, et al. Large animal models of cardiovascular disease. Cell Biochem Funct. 2016;34:113–32. https://doi.org/10.1002/cbf.3173.
CAS Article PubMed PubMed Central Google Scholar
Boucher P, Li W-P, Matz RL, et al. LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome. PLoS One. 2007;2:e448. https://doi.org/10.1371/journal.pone.0000448.
CAS Article PubMed PubMed Central Google Scholar
Takayama Y, May P, Anderson RGW, Herz J. Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta). J Biol Chem. 2005;280:18504–10. https://doi.org/10.1074/jbc.M410265200.
CAS Article PubMed Google Scholar
van der Geer P. Phosphorylation of LRP1: regulation of transport and signal transduction. Trends Cardiovasc Med. 2002;12:160–5. https://doi.org/10.1016/s1050-1738(02)00154-8.
Zhou L, Takayama Y, Boucher P, et al. LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation. PLoS One. 2009;4:e6922. https://doi.org/10.1371/journal.pone.0006922.
CAS Article PubMed PubMed Central Google Scholar
Cal R, García-Arguinzonis M, Revuelta-López E, et al. Aggregated low-density lipoprotein induces LRP1 stabilization through E3 ubiquitin ligase CHFR downregulation in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2013;33:369–77. https://doi.org/10.1161/ATVBAHA.112.300748.
CAS Article PubMed Google Scholar
Muratoglu SC, Mikhailenko I, Newton C, et al. Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-beta in endosomes and regulates activation of the MAPK pathway. J Biol Chem. 2010;285:14308–17. https://doi.org/10.1074/jbc.M109.046672.
CAS Article PubMed PubMed Central Google Scholar
Prasad JM, Migliorini M, Galisteo R, Strickland DK. Generation of a potent low density lipoprotein receptor-related protein 1 (LRP1) antagonist by engineering a stable form of the receptor-associated protein (RAP) D3 domain. J Biol Chem. 2015;290:17262–8. https://doi.org/10.1074/jbc.M115.660084.
CAS Article PubMed PubMed Central Google Scholar
Costales P, Fuentes-Prior P, Castellano J, et al. K domain CR9 of low density lipoprotein (LDL) receptor-related protein 1 (LRP1) is critical for aggregated LDL-induced foam cell formation from human vascular smooth muscle cells. J Biol Chem. 2015;290:14852–65. https://doi.org/10.1074/jbc.M115.638361.
CAS Article PubMed PubMed Central Google Scholar
Yamamoto K, Owen K, Parker AE, et al. Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 binding. J Biol Chem. 2014;289:6462–74. https://doi.org/10.1074/jbc.M113.545376.
CAS Article PubMed PubMed Central Google Scholar
El Asmar Z, Terrand J, Jenty M, et al. Convergent signaling pathways controlled by LRP1 (receptor-related protein 1) cytoplasmic and extracellular domains limit cellular cholesterol accumulation. J Biol Chem. 2016;291:5116–27. https://doi.org/10.1074/jbc.M116.714485.
CAS Article PubMed PubMed Central Google Scholar
Calvier L, Herz J, Hansmann G. Interplay of low-density lipoprotein receptors, LRPs, and lipoproteins in pulmonary hypertension. JACC Basic Transl Sci. 2022;7:164–80. https://doi.org/10.1016/j.jacbts.2021.09.011.
Article PubMed PubMed Central Google Scholar
Boucher P, Gotthardt M, Li W-P, et al. LRP: role in vascular wall integrity and protection from atherosclerosis. Science (1979). 2003;300:329–32.
Overton CD, Yancey PG, Major AS, et al. Deletion of macrophage LDL receptor–related protein increases atherogenesis in the mouse. Circ Res. 2007;100:670–7.
Overton CD, Yancey PG, Major AS, et al. Deletion of macrophage LDL receptor–related protein increases atherogenesis in the mouse. Circ Res. 2007;100:670–7.
Yancey PG, Blakemore J, Ding L, et al. Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. Arterioscler Thromb Vasc Biol. 2010;30:787–95.
Strickland DK, Au DT, Cunfer P, Muratoglu SC. Low-density lipoprotein receptor-related protein-1: role in the regulation of vascular integrity. Arterioscler Thromb Vasc Biol. 2014;34:487–98. https://doi.org/10.1161/ATVBAHA.113.301924.
CAS Article PubMed PubMed Central Google Scholar
Davis FM, Rateri DL, Balakrishnan A, et al. Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms. Arterioscler Thromb Vasc Biol. 2015;35:155–62. https://doi.org/10.1161/ATVBAHA.114.304683.
CAS Article PubMed Google Scholar
Muratoglu SC, Belgrave S, Lillis AP, et al. Macrophage LRP1 suppresses neo-intima formation during vascular remodeling by modulating the TGF-β signaling pathway. PLoS One. 2011;6:e28846. https://doi.org/10.1371/journal.pone.0028846.
CAS Article PubMed PubMed Central Google Scholar
Boucher P, Li W-P, Matz RL, et al. LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome. PLoS One. 2007;2:e448. https://doi.org/10.1371/journal.pone.0000448.
CAS Article PubMed PubMed Central Google Scholar
Giusti B, Galora S, Saracini C, et al. Role of rs1466535 low density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism in carotid artery disease. Atherosclerosis. 2014;237:135–7. https://doi.org/10.1016/j.atherosclerosis.2014.08.049.
CAS Article PubMed Google Scholar
Boucher P, Gotthardt M, Li W-P, et al. LRP: role in vascular wall integrity and protection from atherosclerosis. Science (1979). 2003;300:329–32.
Chan CYT, Chan YC, Cheuk BLY, Cheng SWK. Clearance of matrix metalloproteinase-9 is dependent on low-density lipoprotein receptor-related protein-1 expression downregulated by microRNA-205 in human abdominal aortic aneurysm. J Vasc Surg. 2017;65:509–20. https://doi.org/10.1016/j.jvs.2015.10.065.
Basford JE, Moore ZWQ, Zhou L, et al. Smooth muscle LDL receptor-related protein-1 inactivation reduces vascular reactivity and promotes injury-induced neointima formation. Arterioscler Thromb Vasc Biol. 2009;29:1772–8. https://doi.org/10.1161/ATVBAHA.109.194357.
CAS Article PubMed PubMed Central Google Scholar
Zhou L, Takayama Y, Boucher P, et al. LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation. PLoS One. 2009;4:e6922. https://doi.org/10.1371/journal.pone.0006922.
CAS Article PubMed PubMed Central Google Scholar
Calvier L, Herz J, Hansmann G. Interplay of low-density lipoprotein receptors, LRPs, and Lipoproteins in pulmonary hypertension. JACC Basic Transl Sci. 2022;7:164–80. https://doi.org/10.1016/j.jacbts.2021.09.011. This is a great paper that shows multiple molecular mechanisms guided by the LDLR receptor family and interplays particularly LRP1 with its broad implications in pulmonary vascular wall integrity within other intermediate pathways like Wnt, ApoER2, among others.
Article PubMed PubMed Central Google Scholar
Calvier L, Boucher P, Herz J, Hansmann G. LRP1 deficiency in vascular SMC leads to pulmonary arterial hypertension that is reversed by PPARγ activation. Circ Res. 2019;124:1778–85. Identified and extensively described the importance of LRP1 in smooth muscle cells in the vascular wall in the process of pulmonary hypertension. It relates the findings in this disease model where the deficiency of LRP1 highlights its tissue-specific importance in the process of vascular dysfunction
Zucker MM, Wujak L, Gungl A, et al. LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1604–16. https://doi.org/10.1016/j.bbadis.2019.03.012.
CAS Article PubMed Google Scholar
Au DT, Ying Z, Hernández-Ochoa EO, et al. LRP1 (low-density lipoprotein receptor-related protein 1) regulates smooth muscle contractility by modulating Ca(2+) signaling and expression of cytoskeleton-related proteins. Arterioscler Thromb Vasc Biol. 2018;38:2651–64. https://doi.org/10.1161/ATVBAHA.118.311197.
留言 (0)